https://enovis.com/investors/press-releases/enovis-expands-spinalogic-bone-growth-stimulator-indication-include
Enovis Expands Spinalogic® Bone Growth Stimulator Indication to Include Cervical Fusion | Enovis
Dallas, TX — September 30, 2026 — Enovis™ Corporation (NYSE: ENOV) announced that Spinalogic has received U.S. Food and Drug Administration (FDA) clearance for...
bone growth stimulatorenovisexpandsindicationinclude